Hiroaki Ihara

524 citations
31 papers · 307 indexed · h-index 11
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers)Tuberculosis Research and Epidemiology (5 papers)Mycobacterium research and diagnosis (5 papers)
Partner nations
JapanChina

In The Last Decade

Hiroaki Ihara

25 papers receiving 303 citations

Peers

Hiroaki Ihara
Comparison fields: 5 of 66
  • Pulmonary and Respiratory Medicine 185
  • Molecular Biology 65
  • Oncology 63
  • Epidemiology 48
  • Physiology 47
Replace Alan Tan with:
Alan Tan United States
Junyan Qu China
Fachao Zhi China
Noriyuki Horiguchi Japan
Zamir Kadija Italy
Dong-zhu Zeng China
Gaik W. Tew United States
Minchao Duan China
Wataru Saitoh Japan
Antonia R. Sepulveda United States
Hiroaki Ihara relative to Alan Tan United States Alan Tan's profile →
Citations per field
00.5×5.5×
Alan Tan · 1×
Citations per year

Countries citing papers authored by Hiroaki Ihara

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Ihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ihara more than expected).

Fields of papers citing papers by Hiroaki Ihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ihara. The network helps show where Hiroaki Ihara may publish in the future.

Co-authorship network of co-authors of Hiroaki Ihara

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Ihara. A scholar is included among the top collaborators of Hiroaki Ihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Ihara. Hiroaki Ihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 1
4 0
5 4
6 16
7 1
8 1
9 11
10 1
11 0
12 12
13 10
14 24
15 30
16 20
17 4
18 11
19 9
20 7

About Hiroaki Ihara

Hiroaki Ihara is a scholar working on Microbiology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 31 papers that have together received 307 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Tuberculosis Research and Epidemiology (5 papers) and Mycobacterium research and diagnosis (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (185 citations), Oncology (63 citations) and Physiology (47 citations). Hiroaki Ihara has collaborated with scholars based in Japan and China. Frequent co-authors include Kazuhisa Takahashi, Fumiyuki Takahashi, Motoyasu Kato, Shinichi Sasaki, Kana Kurokawa, Tomoko Yamada, Yusuke Ochi, Takahiro Nakamura, Ken Tajima and Shigeo Takumi. Their work appears in journals such as Scientific Reports, Frontiers in Plant Science and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026